Schwartz Aharon
Insider CIK 1625184 · PLX Director · FOMX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-09 | 8,500 | — | $0 | 8,500 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-09 | 17,000 | — | $0 | 17,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-09 | 8,500 | — | $0 | 8,500 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-09 | 17,000 | — | $0 | 17,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2025-09-03 | 2025-09-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award | 2025-09-03 | 2025-09-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PLX Protalix BioTherapeutics, | P Buy | 2025-06-10 | 2025-08-12 | 129,000 | $1.60 | $206.4K | 303,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2023-09-29 | 2023-10-03 | 61,676 | — | $0 | 61,676 | SEC↗ |
| PLX Protalix BioTherapeutics, | P Buy | 2023-01-03 | 2023-01-05 | 110,000 | $1.42 | $156.2K | 174,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2022-09-07 | 2022-09-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | P Buy | 2020-04-07 | 2020-04-13 | 64,000 | $2.43 | $155.5K | 64,000 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 24,883 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 49,412 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 38,156 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 21,435 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 24,000 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 112,200 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2020-02-27 | 2020-03-03 | 38,156 | — | $0 | 38,156 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2020-01-20 | 2020-01-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2019-05-16 | 2019-05-20 | 49,412 | — | $0 | 49,412 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | P Buy | 2018-11-28 | 2018-12-06 | 12,200 | $3.88 | $47.3K | 112,200 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | P Buy | 2018-11-27 | 2018-12-06 | 50,000 | $3.92 | $196.0K | 100,000 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | P Buy | 2018-11-26 | 2018-12-06 | 50,000 | $3.89 | $194.5K | 50,000 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2018-05-08 | 2018-05-10 | 24,883 | — | $0 | 24,883 | SEC↗ |